InvestorsHub Logo
Followers 18
Posts 634
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Tuesday, 07/05/2022 1:33:16 PM

Tuesday, July 05, 2022 1:33:16 PM

Post# of 8478
Covavax’s efficacy is TIGHT, but consider the rest of the pipeline too!

Read The Mosquito by Dr. Timothy C. Winegard and you’ll realize the global and historical significance of Novavax’s malaria vaccine when standard pharmaceuticals are beginning to lose their edge.

https://www.biopharma-reporter.com/Article/2021/04/26/Malaria-vaccine-candidate-first-to-reach-WHO-goal-with-77-efficacy

NanoFlu has bested High Dose FluZone in trials.

https://www.fiercebiotech.com/biotech/novavax-flu-vaccine-matches-and-beats-sanofi-rival-phase-3

Thus far Novavax’s RSV candidate is still the best in its class considering the current standard is palliative care.

Novavax is simply THE powerhouse delivering the goods.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News